SCHEMBL5204044

SCHEMBL5204044

CC(C)n1cnc(OCc2ccc(F)cc2F)c(Br)c1=O

nearest known ligand 0.51

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 20/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5208575 0.86 MAPK14 (0.53) MAPK14
SCHEMBL27683052 0.82 MAPK14 (0.43) MAPK14
SCHEMBL3523660 0.82 MAPK14 (0.48) MAPK14
SCHEMBL3522196 0.81 MAPK14 (0.53) MAPK14
SCHEMBL3525697 0.81 MAPK14 (0.46) MAPK14
SCHEMBL3522068 0.81 MAPK14 (0.47) MAPK14
SCHEMBL5202380 0.77 MAOB (0.42) MAPK14
SCHEMBL5203606 0.77 MAPK14 (0.47) MAPK14
SCHEMBL5204954 0.77 MAPK14 (0.44) MAPK14
SCHEMBL3522778 0.76 MAPK14 (0.51) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1802590-A1 SUBSTITUTED N-ALKYLPYRIMIDINONES Pharmacia & Upjohn Company LLC (US) 2007-07-04 EP claimed
WO-2006040666-A1 SUBSTITUTED N-ALKYLPYRIMIDINONES PHARMACIA & UPJOHN COMPANY LLC (US) 2006-04-20 WO claimed
EP-1802590-A1 SUBSTITUTED N-ALKYLPYRIMIDINONES Pharmacia & Upjohn Company LLC (US) 2007-07-04 EP disclosed
WO-2006040666-A1 SUBSTITUTED N-ALKYLPYRIMIDINONES PHARMACIA & UPJOHN COMPANY LLC (US) 2006-04-20 WO disclosed